These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
87 related articles for article (PubMed ID: 2203962)
1. Carboxy-terminal peptides from the B subunit of Shiga toxin induce a local and parenteral protective effect. Harari I; Arnon R Mol Immunol; 1990 Jul; 27(7):613-21. PubMed ID: 2203962 [TBL] [Abstract][Full Text] [Related]
2. Synthetic peptides of Shiga toxin B subunit induce antibodies which neutralize its biological activity. Harari I; Donohue-Rolfe A; Keusch G; Arnon R Infect Immun; 1988 Jun; 56(6):1618-24. PubMed ID: 3286503 [TBL] [Abstract][Full Text] [Related]
3. Serological responses to the B subunit of Shiga-like toxin 1 and its peptide fragments indicate that the B subunit is a vaccine candidate to counter action of the toxin. Boyd B; Richardson S; Gariepy J Infect Immun; 1991 Mar; 59(3):750-7. PubMed ID: 1705242 [TBL] [Abstract][Full Text] [Related]
4. Synthetic peptides of Shiga toxin B-subunit induce antibodies which neutralize the biological activities of the toxin. Harari I; Donohue-Rolfe A; Keusch GT; Arnon R Ann Sclavo Collana Monogr; 1986; 3(1-2):125-30. PubMed ID: 3322336 [No Abstract] [Full Text] [Related]
5. Secretory immunoglobulin A response to Shiga toxin in rabbits: kinetics of the initial mucosal immune response and inhibition of toxicity in vitro and in vivo. Keren DF; Brown JE; McDonald RA; Wassef JS Infect Immun; 1989 Jul; 57(7):1885-9. PubMed ID: 2659525 [TBL] [Abstract][Full Text] [Related]
6. Antibodies to shiga holotoxin and to two synthetic peptides of the B subunit in sera of patients with Shigella dysenteriae 1 dysentery. Levine MM; McEwen J; Losonsky G; Reymann M; Harari I; Brown JE; Taylor DN; Donohue-Rolfe A; Cohen D; Bennish M J Clin Microbiol; 1992 Jul; 30(7):1636-41. PubMed ID: 1629317 [TBL] [Abstract][Full Text] [Related]
7. Purification and biological characterization of shiga toxin from Shigella dysenteriae 1. Brown JE; Griffin DE; Rothman SW; Doctor BP Infect Immun; 1982 Jun; 36(3):996-1005. PubMed ID: 7047403 [TBL] [Abstract][Full Text] [Related]
8. Construction of stable LamB-Shiga toxin B subunit hybrids: analysis of expression in Salmonella typhimurium aroA strains and stimulation of B subunit-specific mucosal and serum antibody responses. Su GF; Brahmbhatt HN; Wehland J; Rohde M; Timmis KN Infect Immun; 1992 Aug; 60(8):3345-59. PubMed ID: 1639503 [TBL] [Abstract][Full Text] [Related]
9. A monoclonal antibody to Shigella dysenteriae serotype 13 cross-reacting with Shiga toxin. Qadri F; Azim T; Hossain A; Islam D; Mondol G; Faruque SM; Albert MJ FEMS Microbiol Lett; 1993 Mar; 107(2-3):343-7. PubMed ID: 8472916 [TBL] [Abstract][Full Text] [Related]
10. Production and characterization of monoclonal antibodies with therapeutic potential against Shiga toxin. Islam MS; Stimson WH J Clin Lab Immunol; 1990 Sep; 33(1):11-6. PubMed ID: 1966939 [TBL] [Abstract][Full Text] [Related]
11. Induction of polyclonal and monoclonal antibody responses to cholera toxin by the synthetic peptide approach. Ghose AC; Karush F Mol Immunol; 1988 Mar; 25(3):223-30. PubMed ID: 3374493 [TBL] [Abstract][Full Text] [Related]
12. Pathogenesis of Shigella diarrhea. IX. Simplified high yield purification of Shigella toxin and characterization of subunit composition and function by the use of subunit-specific monoclonal and polyclonal antibodies. Donohue-Rolfe A; Keusch GT; Edson C; Thorley-Lawson D; Jacewicz M J Exp Med; 1984 Dec; 160(6):1767-81. PubMed ID: 6392471 [TBL] [Abstract][Full Text] [Related]
13. A monoclonal antibody to Shigella dysenteriae serotype 13 cross-reacting with Shiga toxin. Qadri F; Azim T; Hossain A; Islam D; Mondal G; Faruque SM; Albert MJ Adv Exp Med Biol; 1995; 371B():923-6. PubMed ID: 7502927 [No Abstract] [Full Text] [Related]
14. Production, characterization and immunodiagnostic application of a monoclonal antibody to Shiga toxin. Qadri F; Mohi MG; Azim T; Faruque SM; Kabir AK; Albert MJ J Diarrhoeal Dis Res; 1996 Jun; 14(2):95-100. PubMed ID: 8870402 [TBL] [Abstract][Full Text] [Related]
15. Oral immunization with a synthetic peptide of cholera toxin B subunit. Obtention of neutralizing antibodies. Guyon-Gruaz A; Delmas A; Pedoussaut S; Halimi H; Milhaud G; Raulais D; Rivaille P Eur J Biochem; 1986 Sep; 159(3):525-8. PubMed ID: 3758076 [TBL] [Abstract][Full Text] [Related]
16. Expression of Shiga toxin epitopes in E. coli immunological characterization. McEwen J; Leitner M; Harari I; Arnon R Immunol Lett; 1989 May; 21(2):157-63. PubMed ID: 2475438 [TBL] [Abstract][Full Text] [Related]
17. Functional analysis of the Shiga toxin and Shiga-like toxin type II variant binding subunits by using site-directed mutagenesis. Jackson MP; Wadolkowski EA; Weinstein DL; Holmes RK; O'Brien AD J Bacteriol; 1990 Feb; 172(2):653-8. PubMed ID: 2404947 [TBL] [Abstract][Full Text] [Related]
18. Animal toxicity of Shigella dysenteriae cytotoxin: evidence that the neurotoxic, enterotoxic, and cytotoxic activities are due to one toxin. Eiklid K; Olsnes S J Immunol; 1983 Jan; 130(1):380-4. PubMed ID: 6336624 [TBL] [Abstract][Full Text] [Related]
19. Characterization of purified Shiga toxin from Shigella dysenteriae 1. Yutsudo T; Honda T; Miwatani T; Takeda Y Microbiol Immunol; 1986; 30(11):1115-27. PubMed ID: 3100915 [TBL] [Abstract][Full Text] [Related]